4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bicycle Therapeutics plc (BCYC) operates in the Biotechnology industry and is headquartered in Cambridge, United Kingdom with about 288 employees. Its market capitalization is roughly $301 million. In the fiscal year ended 2025-12-31, BCYC reported $73M in revenue and ($219M) in net income.
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.
Interactive charts & full statements → Open the BCYC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $73M | $35M | $27M | $14M |
| Operating Income (EBIT) | ($248M) | ($209M) | ($190M) | ($117M) |
| Net Income | ($219M) | ($169M) | ($181M) | ($113M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $48M | $12M | $3M | — |
| Operating Income (EBIT) | ($55M) | ($66M) | ($25M) | ($66M) | ($87M) | — |
| Net Income | ($50M) | ($61M) | ($20M) | ($59M) | ($79M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $718M | $957M | $595M | $411M | — |
| Total Liabilities | $108M | $164M | $224M | $140M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BCYC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms